London, 28-30 September 2010: DigiPharm Europe 2010

We’re excited to be working with the organisers of DigiPharm Europe 2010 conference, which takes place on 28-30 September and is set to be one of Europe’s primary events for digital engagement practitioners in pharmaceutical companies.

The conference will discuss the challenges and strategies used to enhance online communication, customer relationship, strengthen brand awareness and improve profitability in digital marketing.

This event has been designed as a one-stop-shop to the most up to date online marketing strategies, regulatory low down, measuring ROI, analytical tools, pharma case studies and more.

Hear from industry experts including marketing specialists from Lundbeck, Janssen-Cilag, GSK, Schering Plough, Boehringer Ingelheim, Pfizer (Wyeth), Genzyme, Merck Serono and Baxter who will provide a summary of the best current practices and a look at how we can drive digital marketing and communications forward.

Paul Grant and Daniel Ghinn will present the results of new research on reportable adverse events online which will be launched exclusively by Creation Healthcare at DigiPharm Europe 2010. A break out session will review the impact of the findings for pharmaceutical companies engaging patients digitally. The session will review international regulatory variations and consider new insights, covering:

  • What kind of social media conversations are likely to result in reportable adverse events?
  • Are there variations in the prevalence of reportable adverse events online by therapeutic area, platform, country or language?
  • How can pharmaceutical companies choose the most effective digital engagement channels to suit their approach to handling reportable adverse events?

Find out more about DigiPharm Europe 2010.

Through truly impartial advice about strategy and implementation, Creation Healthcare helps organisations develop initiatives which are aligned with business goals, and which deliver return on investment.